Cephalon (CEPH) options active on flat volatility; shares sell off 7% on clinical trial
Tweet Send to a Friend
Cephalon (Nasdaq: CEPH) is recently down $5.83 to $53.78. Cephalon Phase IIb/III Cinquil trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
